INSIDER
In addition to availability, the cost of weight loss drugs like Wegovy and Zepbound is a major barrier preventing many Americans from using these medications.
I don’t want to just dismiss a potential miracle cure without giving it a little thought -- but it seems every time I look -- social media has come up with some new trend that makes incredible promises.
The World Health Organization and drugmaker Eli Lilly and Co. are warning patients to be wary of fake versions of weight-loss and diabetes medicines.
The Federal Trade Commission is challenging patents on 20 brand-name drugs, including the blockbuster weight-loss injection Ozempic.
For a Minnesota minor league baseball team known for a history of outlandish promotions, the idea of naming its longtime live pig mascot after the weight loss drug Ozempic made perfect sense.
The manager of the world’s largest sovereign wealth fund is pledging to push major oil and gas companies to speed up preparations for the “inescapable” transition away from fossil fuels.
The U.S. Food and Drug Administration says it has seized “thousands of units” of counterfeit Ozempic, the diabetes drug widely used for weight loss.
A new large study finds that the popular weight-loss drug Wegovy reduced the risk of serious heart problems by 20% in certain patients.
Supply problems and insurance complications have made it difficult for many patients to start and stay on new prescription medications used to treat obesity.
The U.S. Food and Drug Administration is warning consumers not to use versions of the popular weight-loss drug used in Ozempic and Wegovy and sold online because they might not contain the same ingredients as prescription products and may not be safe or effective.
Obesity is a major and growing problem around the world, but especially in the U.S. Researchers have long looked for medications that can help people lose weight, mostly with disappointing and, in some cases, dangerous results.
